PHAT compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

PHATPhathom Pharmaceuticals, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

PHATPhathom Pharmaceuticals, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

PHATPhathom Pharmaceuticals, Inc.

5.75▼−2.87%· post 5.75

Mkt cap$480.8MRevenue$85MQ3 FY26Revenue$175MFY25

LLYELI Lilly & Co

1,407.25▼−0.27%· post 1,416.42

ClosedNov 3 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 3 '26

PHATPhathom Pharmaceuticals, Inc.

LLYELI Lilly & Co

5.75▼−2.87%post 5.75

Price

1,407.25▼−0.27%post 1,416.42

$480.8M

Mkt cap

$1.3T

Q3 FY26$85M

Revenue

$24.4BQ3 FY26

FY25$175M

Revenue

$65.2BFY25

PHAT5.75▼−2.87%vsLLY1,407.25▼−0.27%ClosedNov 3 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

PHAT: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PHAT 2

—Takeda Pharmaceuticalunlistedsupplier

—Sandozunlistedsupplier

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

Price

rebased to 0%

PHAT, solidLLY, dashed